Loading...
Market
What will CVS Caremark's response be to the settlement by end of 2024?
2
Resolution / Starting Odds
Announce internal policy changes • 25%
Face additional lawsuits • 25%
No significant actions taken • 25%
Announce new partnerships or acquisitions • 25%
Official statements from CVS Caremark, regulatory filings, or news reports
Story
CVS Caremark Quietly Agrees to Pay $45 Million to Settle Illinois Drug Rebate Allegations Over Four-Year Period
Jul 23, 2024, 11:18 PM
CVS Caremark has quietly agreed to pay $45 million to the state of Illinois to settle allegations that it failed to pass drug rebates through to consumers over a recent four-year period. The settlement addresses claims that CVS's pharmacy benefit manager (PBM) inappropriately pocketed drug rebates through a subsidiary known as Zinc, a 'rebate aggregator,' according to a document obtained by STAT.
View original story
Similar markets
Yes • 50%
No • 50%
CVS found guilty • 25%
Ongoing litigation • 25%
CVS found liable • 25%
CVS settles • 25%
Case dismissed • 25%
Other outcome • 25%
Yes • 50%
No • 50%
No penalty • 25%
Less than $500 million • 25%
$500 million to $1 billion • 25%
Over $1 billion • 25%
Yes • 50%
No • 50%
CVS found liable • 25%
CVS settles • 25%
CVS not liable • 25%
Case dismissed • 25%